Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis.
Saved in:
| Title: | Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis. |
|---|---|
| Authors: | Situ M; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada., Schwarz UI; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada., Zou G; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada.; Alimentiv Inc, London, ON, Canada., McArthur E; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada., Kim RB; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada., Garg AX; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada., Sarma S; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada. ssarma2@uwo.ca.; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada. ssarma2@uwo.ca.; Lawson Health Research Institute, London, ON, Canada. ssarma2@uwo.ca. |
| Source: | The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Apr; Vol. 25 (3), pp. 397-409. Date of Electronic Publication: 2023 May 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37195343 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Situ+M%22">Situ M</searchLink>; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada.<br /><searchLink fieldCode="AU" term="%22Schwarz+UI%22">Schwarz UI</searchLink>; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.<br /><searchLink fieldCode="AU" term="%22Zou+G%22">Zou G</searchLink>; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada.; Alimentiv Inc, London, ON, Canada.<br /><searchLink fieldCode="AU" term="%22McArthur+E%22">McArthur E</searchLink>; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Kim+RB%22">Kim RB</searchLink>; Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.<br /><searchLink fieldCode="AU" term="%22Garg+AX%22">Garg AX</searchLink>; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada.; Lawson Health Research Institute, London, ON, Canada.; Department of Medicine, Schulich School of Medicine and Dentistry, Western University, ON, London, Canada.<br /><searchLink fieldCode="AU" term="%22Sarma+S%22">Sarma S</searchLink>; Department of Epidemiology and Biostatistics, Western Centre for Public Health and Family Medicine, Schulich School of Medicine and Dentistry, Western University, 1465 Richmond Street, ON, N6G 2M1, London, Canada. ssarma2@uwo.ca.; ICES (Formerly the Institute for Clinical Evaluative Sciences), Toronto, ON, Canada. ssarma2@uwo.ca.; Lawson Health Research Institute, London, ON, Canada. ssarma2@uwo.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101134867%22">The European journal of health economics : HEPAC : health economics in prevention and care</searchLink> [Eur J Health Econ] 2024 Apr; Vol. 25 (3), pp. 397-409. <i>Date of Electronic Publication: </i>2023 May 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101134867 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1618-7601 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216187598%22">16187598 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Health Econ <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37195343 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10198-023-01594-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 397 Titles: – TitleFull: Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Situ M – PersonEntity: Name: NameFull: Schwarz UI – PersonEntity: Name: NameFull: Zou G – PersonEntity: Name: NameFull: McArthur E – PersonEntity: Name: NameFull: Kim RB – PersonEntity: Name: NameFull: Garg AX – PersonEntity: Name: NameFull: Sarma S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2024 Apr Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1618-7601 Numbering: – Type: volume Value: 25 – Type: issue Value: 3 Titles: – TitleFull: The European journal of health economics : HEPAC : health economics in prevention and care Type: main |
| ResultId | 1 |
